— Know what they know.
Not Investment Advice

VASO OTC

Vaso Corporation
1W: +0.3% 1M: +2.0% 3M: +55.8% YTD: +73.8% 1Y: +153.9% 3Y: -10.3% 5Y: +491.9%
$0.30
+0.00 (+1.70%)
 
Weekly Expected Move ±6.7%
$0 $0 $0 $0 $0
OTC · Healthcare · Medical - Healthcare Information Services · Tech Score Neutral · Power 62 · $52.1M mcap · 99M float · 0.152% daily turnover · Short 21% of daily vol

Cash Flow Trends

Operating Cash Flow
$3M -38.0% ▼
Capital Expenditures
$1M -98.8% ▼
5Y CAGR: +3.8%
Free Cash Flow
$2M -60.0% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$8K -33.3% ▼
Net Change in Cash
$15M +3216.7% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$358K$6M$12M$5M$951K
Depreciation & Amort.$2M$4M$2M$996K$824K
Stock-Based Comp.$88K$31K$35K$48K$54K
Change in Working Capital$3M$532K$5M-$3M-$196K
Other Non-Cash Items$542K-$3M$217K$2M$2M
Operating Cash Flow$6M$8M$14M$5M$3M
— Investing Activities —
Capital Expenditures-$1M-$415K-$566K-$731K-$1M
Acquisitions (Net)$1M$0$566K$0$0
Investment Purchases-$725K$0-$8M-$24M$0
Investment Sales-$150K$155K$149K$20M$14M
Other Investing$150K$155K-$566K-$5M-$573K
Investing Cash Flow-$575K-$260K-$8M-$6M$12M
— Financing Activities —
Net Debt Issuance-$549K-$8M-$230K-$128K-$81K
Stock Repurchased-$4K$0$0-$6K-$8K
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$0$0
Financing Cash Flow-$553K-$8M-$230K-$134K-$89K
Net Change in Cash$5M-$794K$6M-$479K$15M
Cash End of Period$7M$6M$12M$11M$26M
Free Cash Flow$5M$7M$14M$5M$2M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms